Biotechs Face Daunting Launch Environment Going It Alone

Q2 Updates From Biohaven, UroGen, Amarin And Others

 
• By Jessica Merrill

Several small biotechs are launching new drugs independently in a launch environment that now presents unexpected challenges caused by COVID-19.

Woman Ascending Stairs
Biotechs launching alone face an even more challenging environment • Source: Shutterstock

More from Earnings

More from Business